Immune Checkpoints in Thymic Epithelial Tumors: Challenges and Opportunities

Immuno-Oncology Technology
doi 10.1016/j.iotech.2019.09.002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Immune Checkpoint Inhibitor Combinations in Solid Tumors: Opportunities and Challenges

Immunotherapy
OncologyAllergyImmunology
2016English

ES08.03 Mesothelioma, Thymic Epithelial Tumors and Others

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Novel Biologic Therapies for Thymic Epithelial Tumors

Frontiers in Oncology
Cancer ResearchOncology
2014English

P1.14-21 Circulating Biomarkers in Thymic Epithelial Tumors

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Detection of Human Polyomavirus 7 in Human Thymic Epithelial Tumors

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2015English

PI3K as a Potential Therapeutic Target in Thymic Epithelial Tumors

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Low Prevalence of Merkel Cell Polyomavirus in Human Epithelial Thymic Tumors

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2019English

Immunotherapeutic Potential of CD4 and CD8 Single-Positive T Cells in Thymic Epithelial Tumors

Scientific Reports
Multidisciplinary
2020English

Radiologic Response to Neoadjuvant Treatment Predicts Histologic Response in Thymic Epithelial Tumors

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy